Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 15 February, 2012 and appeared in  DietNeurologyPathologyIssue 613

Mediterranean Diet Associated with Reduced Small Vessel Damage in the Brain

Consumption of a Mediterranean-style diet is associated with a reduced burden of white matter hyperintesity volume, a marker of small vessel damage in the brain....

Advertisement

The authors write, white matter hyperintensities (WMHs) visible on brain magnetic resonance imaging (MRI) are markers of chronic small vessel damage, according to background information in the article. "Although diet may be an important predictor of vascular disease, little is known about the possible association between dietary habits and WMHs. "Studies have suggested that consumption of a MeDi [Mediterranean Diet] is associated with a reduced risk of the metabolic syndrome, coronary heart disease, stroke and cognitive disorders, but no studies to date, to our knowledge, have examined the association between a MeDi and WMH volume (WMHV)." 

Hannah Gardener, Sc.D., of the University of Miami Miller School of Medicine, and colleagues evaluated data from 966 participants in the Northern Manhattan Study to examine the association between a MeDi and WMHV. Participants were given a food frequency questionnaire to assess dietary patterns during the previous year, and answers were used to determine a MeDi compliance score. The WMHV was measured by quantitative brain MRI.

Results of the survey showed that 11.6 percent of participants scored 0 to 2 on the MeDi scale, 15.8 percent scored 3, 23 percent scored 4, 23.5 percent scored 5, and 26.1 percent scored 6 to 9. Women had lower MeDi scores than men and participants who reported moderate to heavy levels of physical activity were more likely to report greater consumption of a MeDi. Participants with MeDi scores of 6 or higher also had lower BMI.

These results suggest a lower burden of WMHV among participants with a greater consumption of a MeDi. This association was independent of sociodemographic and vascular risk factors including physical activity, smoking, blood lipid levels, hypertension, diabetes, history of cardiac disease and BMI. Additionally, after adjustment, the only component of the MeDi score that was independently associated with WMHV was the ratio of monounsaturated to saturated fat.

"In summary, the current study suggests a possible protective association between increased consumption of a MeDi and small vessel damage," the authors conclude. "The associations with WMHV may be driven by the favorable ratio of monounsaturated fat consumption over saturated fat. However, the results of the analysis of the individual MeDi scale components suggest that the overall dietary pattern, rather than any of the individual components, may be more etiologically relevant in relation to WMHV."

Arch Neurol. Feb. 2012;69[2]:251-256.
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 15 February, 2012 and appeared in  DietNeurologyPathologyIssue 613

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

2012 Most Popular Articles:

ADA/EASD Issue New Hyperglycemia Management Guidelines
Posted April 26, 2012
Type 2 More Dangerous in Children
Posted May 03, 2012
It’s the Variety of Fruit-and-Veggie That Lower Diabetes Risk
Posted May 03, 2012
Questioning Carbohydrate Restriction in Diabetes Management
Posted May 18, 2012
Ultra-Long-Acting Insulin Degludec, Two New Studies
Posted April 26, 2012
Eating Low Glycemic Index Foods at Breakfast Can Control Blood Sugar throughout the Day
Posted April 18, 2012
Metformin May Treat a Leading Cause of Blindness
Posted May 10, 2012
A Candy Treatment that Fights Diabetes and May Replace TZD's?
Posted May 10, 2012
Metformin May Not Be the Golden Pill After All for Treating Type 2 Diabetes
Posted April 18, 2012
Doubts Over Long Term Effectiveness of Group Education for Diabetes Patients
Posted May 03, 2012

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:
CME/CE of the Week
John Steinberg, DPM

Category: Diabetic Foot
Credits:
 .75


Advertisement


Search Articles On Diabetes In Control